USP General Notices and General Test Chapters: Interpretations and Misinterpretations

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-10-02-2004, Volume 28, Issue 10

The authors dispel common misinterpretations of the United States Pharmacopeia.

Related Content:

Quality SystemsStandard Operating ProceduresCompendial CompliancePharmaceutical Technology-10-02-2004
FDA Reports on Status of Postmarketing Requirements and Postmarketing Commitments
Novartis’ Radioligand Therapy Gains FDA Nod for Pediatric Patients
Navigating an Uncertain Regulatory Environment for mRNA-based Products